HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Unveils Overview of COVID-19 Vaccine Distribution Scheme in Japan
December 11, 2020
-
BUSINESS Boehringer Speeding Up Growth of Jardiance on Organization, Alliance Rejig; 40 Billion Yen Japan Sales Likely in 2020
December 11, 2020
-
BUSINESS Aducanumab Submitted in Japan, but Decision Unlikely to Come Until Next Autumn
December 11, 2020
-
BUSINESS Biogen Files Japan NDA for Aducanumab
December 10, 2020
-
REGULATORY Chuikyo Healthcare Reps Urge Minimal Scope for Off-Year Re-Pricing, Payers Grumble over Generic-Heavy Coverage
December 10, 2020
-
BUSINESS Takeda Aiming for Sales of 5 Trillion Yen by FY2030, Sees It Realistic Target with Strong Pipeline
December 10, 2020
-
REGULATORY MHLW Estimates: Off-Year Re-Pricing with Average Price Gap Threshold Likely to Hit 8,700 Products, Save 360 Billion Yen
December 9, 2020
-
BUSINESS Kyle Tattle to Take Reins of MSD Japan from January
December 8, 2020
-
REGULATORY MHLW Panel OKs Takeda’s ALK Drug, Lynparza’s Pancreatic Cancer Use; Seikagaku’s Osteoarthritis Med Put under Continued Review
December 7, 2020
-
REGULATORY Gardasil’s Male Indication in Line for OK as Early as This Month
December 7, 2020
-
BUSINESS Kobayashi Kako Recalls Itraconazole over Hypnotic Contamination; Side Effects Confirmed
December 7, 2020
-
REGULATORY Yescarta Sails through PAFSC Review; Panel Roughly OKs Novartis’ Corrective Measures after Zolgensma Delay
December 4, 2020
-
BUSINESS Sandoz to Discontinue Filgrastim Biosimilars; Late Market Entry a Factor
December 4, 2020
-
REGULATORY Chuikyo Reps Raise No Opposition to Off-Year Re-Pricing, Still Split over Product Scope
December 3, 2020
-
REGULATORY MHLW to Issue Notification to Urge Drug Makers’ Prompt Info Provisioning on Supply Shortages
December 3, 2020
-
REGULATORY Average NHI-Market Price Gap at 8.0%: MHLW
December 2, 2020
-
BUSINESS Sanofi Japan to Sharpen Focus on Priority Pipelines as It Eyes Turnaround after 2022: President
December 1, 2020
-
BUSINESS Demand for Nesp Biosimilars Spiking as Hospitals Turn to Cheaper Meds in Dialysis Care, Shipment Control Triggered
December 1, 2020
-
REGULATORY MHLW Approves Label Expansions for Forxiga, Trelegy, Evrenzo, Cabometyx and More
November 30, 2020
-
REGULATORY Japan to Set New Generic Target by March-End: Health Minister
November 30, 2020
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
